Factors contributing to the differences in peritonitis rates between centers and regions

Peritoneal Dialysis International

Volumn 27, Issue SUPPL. 2, 2007, Pages

  Stinghen, Andrea E ^a   Barretti, Pasqual ^b   Pecoits Filho, Roberto ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Complications; Infection; Peritonitis; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; PSEUDOMONIC ACID;

ANAEROBIC BACTERIUM; BACTERIAL INFECTION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONFERENCE PAPER; FUNGUS; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; MORBIDITY; NONHUMAN; PATIENT SELECTION; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL;

AMBULATORY CARE FACILITIES; CATHETERS, INDWELLING; DIALYSIS SOLUTIONS; EQUIPMENT CONTAMINATION; HUMANS; PATIENT SELECTION; PERITONEAL DIALYSIS; PERITONITIS; RISK FACTORS; SANITATION; SOCIOECONOMIC FACTORS; WEATHER;

EID: 35748944890     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Dawson MS, Harford AM, Garner BK, Sica DA, Landwehr DM, Dalton HP. Total volume culture technique for the isolation of micro-organisms from continuous ambulatory peritoneal dialysis patients with peritonitis, J Clin Microbiol 1985; 22:391-4.
2. Findon G, Miller T. Bacterial peritonitis in continuous ambulatory peritoneal dialysis: effect on dialysis on host defense mechanisms. Am J Kidney Dis 1995; 26:765-73.
3. Troidle L, Finkelstein F. Treatment and outcome of CPD-associated peritonitis. Ann Clin Microbiol Antimicrob 2006; 5: 6.
4. Miskulin DC, Meyer KB, Athienites NV, Martin AA, Terrin N, Marsh JV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 2002; 39:324-36.
5. Szeto CC, Chow KM, Wong TY, Leung CB, Li PK. Influence of climate on the incidence of peritoneal dialysis-related peritonitis. Perit Dial Int 2003; 23:580-6.
6. Kim MJ, Song JH, Park YJ, Kim GA, Lee SW. The influence of seasonal factors on the incidence of peritonitis in continuous ambulatory peritoneal dialysis in the temperate zone. Adv Perit Dial 2000; 16:243-7.
7. Alves FR, Dantas RC, Lugon JR. Higher incidence of catheter-related infections in a tropical climate. Adv Perit Dial 1993; 9:244-7.
8. Quinn MJ, Hasbargen JA, Hasbargen BJ. When does peritonitis occur? Perit Dial Int 1994; 14:172-4.
9. Thodis E, Passadakis P, Vargemezis V, Oreopoulos DG. Peritoneal dialysis: better than, equal to, or worse than hemodialysis? Data worth knowing before choosing a diarysis modality. Perit Dial Int 2001; 21:25-35.
10. Holley JL, Bernardini J, Perlmutter JA, Piraino B. A comparison of infection rates among order and younger patients on continuous peritoneal dialysis. Perit Dial Int 1994; 14:66-9.
11. Chow KM, Szeto CC, Leung CB, Law MC, Li PK. Impact of social factors on patients on peritoneal dialysis. Nephrol Dial Transplant 2005; 20:2504-10.
12. Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, et al. Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group. Nephrol Dial Transplant 1994; 9:1443-8.
13. Wang Q, Bernardini J, Piraino B, Fried L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis 2003; 41:664-9.
14. Lee HY, Kim YK, Kang SW, Lee HW, Choi KH, Han DS. Influence of nutritional status on CAPD peritonitis. Yonsei Med J 1990; 31:65-70.
15. Wu CH, Huang CC, Wu MS, Yang CW, Huang JY, Fang JT, et al. Total creatinine appearance as indicator of risk of infectious complication in peritoneal dialysis. Adv Perit Dial 2000; 16:219-22.
16. McDonald SP, Collins JF, Rumpsfeld M, Johnson DW. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int 2004; 24:340-6.
17. Pecoits-Filho R, Carvalho MJ, Stenvinkel P, Lindholm B, Heimbürger O. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis. Perit Dial Int 2006; 26:53-63.
18. Farias MG, Soucie JM, McClellan W, Mitch WE. Race and the risk of peritonitis: an analysis of factors associated with the initial episode. Kidney Int 1994; 46:1392-6.
19. Juergensen PH, Gorban-Brennan N, Troidle L, Finkelstein FO. Racial differences and peritonitis in an urban peritoneal dialysis center. Adv Perit Dial 2002; 18:117-18.
20. Lim WH, Johnson DW, McDonald SP. Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton) 2005; 10:192-7.
21. Caramori J, Barretti P, Soares V. Risk factors for peritonitisin CAPD. Multivariate analysis. In: Abstracts of the XVth international Congress of Nephrology; 2-6 May 1999; Buenos Aires, Argentina. Buenos Aires: International Society of Nephrology; 1999: 309.
22. Whaley-Connell A, Pavey BS, Satalowich R, Prowant BF, Misra M, Twardowski ZJ, et al. Rates of continuous ambulatory peritoneal dialysis-associated peritonitis at the University of Missouri. Adv Perit Dial 2005; 21:72-5.
23. Bonifati C, Pansini F, Torres DD, Navaneethan SD, Craig JC, Strippoli GF. Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: using evidence in the context of clinical practice. Int J Artif Organs 2006; 29:41-9.
24. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004; 24:424-32.
25. Chen CM, Ho MW, Yu WL, Wang JH. Fungal peritonitis in peritoneal dialysis patients: effect of fluconazote treatment and use of the twin-bag disconnect system, J Microbiol Immunol Infect 2004; 37:115-20.
26. Van Biesen W, Veys N, Vanholder R, Lameire N. Peritoneal-dialysis-related peritonitis: the art of rope-dancing. Nephrol Dial Transplant 2002; 17:1878-82.
27. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37:1629-38.
28. Perez-Fontán M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002; 39:337-41.
29. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16: 539-45.
30. de Fijter CW, Oe LP, Nauta JJ, van der Meulen J, Verbrugh HA, Verhoef J, et al. Clinical efficacy and morbidity assodated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 1994; 120: 264-71.
31. Oo TN, Roberts TL, Collins AJ. A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 2005; 45:372-80.
32. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
33. Lee HY, Choi HY, Park HC, Seo BJ, Do 3Y, Yun SR, et al. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 2006; 21:2893-9.